Bovine Respiratory Disease Treatment Market By: Disease Type, By Treatment Type, By End User and Region Forecast 2020-2031
Bovine Respiratory Disease Treatment Market size was valued at US$ 71 million in 2023 and is expected to reach 98 million by 2030, at a CAGR of 8.2% from 20224 to 2030. Some of the key factors influencing the market growth include the growing demand for bovine respiratory disease treatment due to the large consumption of beef and other dairy products. Rising awareness among people relating to these infections makes them cautious in taking qualified beef which increases the demand for vaccines and other treatment types for these diseases. Also, farm maintainers are giving more importance to this treatment as these bovine diseases are one of the major causes of morbidity and mortality in the cattle species.
The report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed the global market to better equip clients with possible investment opportunities across the regions (Regional Investment hot spots) and market unmet needs (Product opportunities).
Study Period
2025-2031Base Year
2024CAGR
8.2%Largest Market
North-AmericaFastest Growing Market
North-America
Bovine respiratory disease treatments helps in early detection of the diseases, prevention of spreading and curing the diseases in the cattle species. According to recent surveys around 45-65% of mortality of cattle occurs due to these bovine infections. Prevention and treatment of these diseases is much more demanded and necessary in these conditions which rises the demand for the bovine respiratory disease treatments. These treatments are majorly required due to the demand for beef and other dairy products.
North America accounted for larger revenue share in market with considerable CAGR. The growth in this region can be attributed to high consumption of beef in this region, and other dairy products. Presence of large cattle rearing industries, availability of more advanced treatment facilities, more research opportunities, more research funding etc. increases the market for bovine respiratory tract infection treatment market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2023 |
US$ 71 million |
|
Market CAGR |
8.2% |
|
By Disease Type |
|
|
By Treatment Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The bovine respiratory disease treatment market size was valued at US$ 71 million in 2023 and will reach 98 million by 2030, at a CAGR of 8.2%.
AgriLabs, Bayer AG HealthCare, Bimeda Animal Health, Boehringer Ingelheim International GmbH, Ceva
North America is the fastest-growing region in the market
| 1. Executive Summary |
| 2. Global Bovine Respiratory Disease Treatment Market Introduction |
| 2.1.Global Bovine Respiratory Disease Treatment Market - Taxonomy |
| 2.2.Global Bovine Respiratory Disease Treatment Market - Definitions |
| 2.2.1.Disease Type |
| 2.2.2.Treatment Type |
| 2.2.3.End Users |
| 2.2.4.Region |
| 3. Global Bovine Respiratory Disease Treatment Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Bovine Respiratory Disease Treatment Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Bovine Respiratory Disease Treatment Market By Disease Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Lower Respiratory Tract Infections |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Upper Respiratory Tract Infections |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Diphtheria |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Bovine Respiratory Disease Treatment Market By Treatment Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Vaccines |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Antibiotics |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. NSAIDs |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Immuno-modulators |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Other Treatment Types |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Bovine Respiratory Disease Treatment Market By End Users, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Veterinary Clinics |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Veterinary Hospitals |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Veterinary Research Institutes |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Private Veterinary |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Bovine Respiratory Disease Treatment Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Bovine Respiratory Disease Treatment Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Lower Respiratory Tract Infections |
| 9.1.2.Upper Respiratory Tract Infections |
| 9.1.3.Diphtheria |
| 9.2. Treatment Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Vaccines |
| 9.2.2.Antibiotics |
| 9.2.3.NSAIDs |
| 9.2.4.Immuno-modulators |
| 9.2.5.Other Treatment Types |
| 9.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Veterinary Clinics |
| 9.3.2.Veterinary Hospitals |
| 9.3.3.Veterinary Research Institutes |
| 9.3.4.Private Veterinary |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Bovine Respiratory Disease Treatment Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Disease Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Lower Respiratory Tract Infections |
| 10.1.2.Upper Respiratory Tract Infections |
| 10.1.3.Diphtheria |
| 10.2. Treatment Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Vaccines |
| 10.2.2.Antibiotics |
| 10.2.3.NSAIDs |
| 10.2.4.Immuno-modulators |
| 10.2.5.Other Treatment Types |
| 10.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Veterinary Clinics |
| 10.3.2.Veterinary Hospitals |
| 10.3.3.Veterinary Research Institutes |
| 10.3.4.Private Veterinary |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Bovine Respiratory Disease Treatment Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Disease Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Lower Respiratory Tract Infections |
| 11.1.2.Upper Respiratory Tract Infections |
| 11.1.3.Diphtheria |
| 11.2. Treatment Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Vaccines |
| 11.2.2.Antibiotics |
| 11.2.3.NSAIDs |
| 11.2.4.Immuno-modulators |
| 11.2.5.Other Treatment Types |
| 11.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Veterinary Clinics |
| 11.3.2.Veterinary Hospitals |
| 11.3.3.Veterinary Research Institutes |
| 11.3.4.Private Veterinary |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Bovine Respiratory Disease Treatment Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Disease Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Lower Respiratory Tract Infections |
| 12.1.2.Upper Respiratory Tract Infections |
| 12.1.3.Diphtheria |
| 12.2. Treatment Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Vaccines |
| 12.2.2.Antibiotics |
| 12.2.3.NSAIDs |
| 12.2.4.Immuno-modulators |
| 12.2.5.Other Treatment Types |
| 12.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Veterinary Clinics |
| 12.3.2.Veterinary Hospitals |
| 12.3.3.Veterinary Research Institutes |
| 12.3.4.Private Veterinary |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Bovine Respiratory Disease Treatment Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Disease Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Lower Respiratory Tract Infections |
| 13.1.2.Upper Respiratory Tract Infections |
| 13.1.3.Diphtheria |
| 13.2. Treatment Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Vaccines |
| 13.2.2.Antibiotics |
| 13.2.3.NSAIDs |
| 13.2.4.Immuno-modulators |
| 13.2.5.Other Treatment Types |
| 13.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Veterinary Clinics |
| 13.3.2.Veterinary Hospitals |
| 13.3.3.Veterinary Research Institutes |
| 13.3.4.Private Veterinary |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.AgriLabs |
| 14.2.2.Bayer AG HealthCare |
| 14.2.3.Bimeda Animal Health |
| 14.2.4.Boehringer Ingelheim International GmbH |
| 14.2.5.Ceva |
| 14.2.6.Elanco |
| 14.2.7.Inovio Pharmaceuticals |
| 14.2.8.Intervet Inc. |
| 14.2.9.Merck |
| 14.2.10.Merial |
| 14.2.11.Norbrook Laboratories |
| 14.2.12.Plumbline Life Sciences |
| 14.2.13.Vetoquinol S.A., |
| 14.2.14.Virbac Group. |
| 14.2.15.Zoetis Services LLC |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
